Composition
- Active ingredients
- METHOTREXATE 22.5MG/0.4ML (22.5MG/0.4ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- METHOTREXATE 22.5MG/0.4ML (22.5MG/0.4ML) · SolutionThis page
- METHOTREXATE 12.5MG/0.4ML (12.5MG/0.4ML) · SolutionNDA204824-006 · Discontinued
- METHOTREXATE 25MG/0.4ML (25MG/0.4ML) · SolutionNDA204824-004 · Discontinued
- METHOTREXATE 15MG/0.4ML (15MG/0.4ML) · SolutionNDA204824-002 · Discontinued
- METHOTREXATE 17.5MG/0.4ML (17.5MG/0.4ML) · SolutionNDA204824-007 · Discontinued
- METHOTREXATE 7.5MG/0.4ML (7.5MG/0.4ML) · SolutionNDA204824-005 · Discontinued
- METHOTREXATE 20MG/0.4ML (20MG/0.4ML) · SolutionNDA204824-003 · Discontinued
- METHOTREXATE 10MG/0.4ML (10MG/0.4ML) · SolutionNDA204824-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA204824.
At a glance
- Brand name
- Otrexup
- Active substance
- methotrexate
- Route
- Subcutaneous
- Dosage form
- Solution
- Applicant
- Assertio Speclty
- Status
- Discontinued
- FDA approval
- 11 Oct 2013
- Application
- NDA204824-008